The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.

The acceptability of the combined contraceptive vaginal ring, NuvaRing, was assessed during two trials conducted in North America and Europe. Women completed a questionnaire about the ring's clarity of instructions, ease of use, sexual comfort, cycle-related characteristics and satisfaction after 3, 6 and 13 cycles of use. A total of 1,950 women (82% of those recruited) completed a questionnaire at cycle 3. At baseline, 66% of participants preferred oral contraceptives, but after three cycles of ring use 81% preferred the ring. On study completion, 97% agreed that the instructions for use were clear; 85% of women and 71% of their partners never/rarely felt the ring during intercourse and 94% of partners never/rarely minded that the woman was using the ring. Overall acceptance was high, 96% were satisfied with the ring and 97% would recommend the ring. Similar responses were seen for women who prematurely discontinued from the studies, except that slightly fewer women were satisfied (60%) and would recommend the ring (75%). Reasons for liking the ring included 'not having to remember anything' (45%) and 'ease of use' (27%). In conclusion, there is a high level of user and partner acceptability for the contraceptive ring.

[1]  C. Egarter,et al.  Low dose oral contraceptives and quality of life. , 1999, Contraception.

[2]  D. Apter,et al.  Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. , 2001, Human reproduction.

[3]  P. D. De Silva,et al.  A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives. , 1993, Contraception.

[4]  J. Foidart,et al.  Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone , 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[5]  H. Rekers Multicenter Trial of a Monophasic Oral Contraceptive Containing Ethinyl Estradiol and Desogestrel , 1988, Acta obstetricia et gynecologica Scandinavica.

[6]  J. Hanker,et al.  A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles , 1997 .

[7]  M. Tuppurainen,et al.  Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. , 2002, American journal of obstetrics and gynecology.

[8]  C. Timmer,et al.  Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal Ring , 2000, Clinical pharmacokinetics.

[9]  D. Apter,et al.  Efficacy, Cycle Control, and User Acceptability of a Novel Combined Contraceptive Vaginal Ring , 2002, Obstetrics and gynecology.

[10]  C. Gerlinger,et al.  Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 μg ethinylestradiol/100 μg levonorgestrel and 20 μg ethinylestradiol/500 μg norethisterone , 2001 .

[11]  J. Ranstam,et al.  Oral contraceptive use among young women in southern Sweden. , 1993, Journal of epidemiology and community health.

[12]  C. Gerlinger,et al.  Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel , 2001 .

[13]  T. Eskes,et al.  Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive , 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[14]  Caroline Bird,et al.  What Women Want , 1979 .

[15]  D. Shoupe Multicenter Randomized Comparative Trial of Two Low‐Dose Triphasic Combined Oral Contraceptives Containing Desogestrel or Norethindrone , 1994, Obstetrics and Gynecology.

[16]  B. Oddens,et al.  The dynamics of oral contraceptive use in the Netherlands 1990–1993 , 1994, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[17]  J. Rosenfeld,et al.  Women's satisfaction with birth control. , 1993, The Journal of family practice.

[18]  B J Oddens,et al.  Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women. , 1999, Contraception.

[19]  M. Rosenberg,et al.  Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. , 1995, Contraception.

[20]  A. Kaunitz Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial. , 2000, Contraception.